10-Q: FutureFuel Corp. Reports Mixed Q3 Results Amidst Production Challenges and Market Volatility

FutureFuel Corp. experienced a significant revenue decrease in Q3 2024 due to production issues and lower biofuel prices, resulting in a net loss for the quarter.

Summary

• FutureFuel Corp. reported a net loss of $1.195 million for the third quarter of 2024, a significant downturn compared to a net income of $2.776 million in the same period last year.
• The company's revenue decreased by 56% to $51.140 million in Q3 2024, down from $116.752 million in Q3 2023, primarily due to lower sales volumes and prices in the biofuel segment.
• For the nine months ended September 30, 2024, FutureFuel reported a net income of $12.706 million, a decrease from $13.998 million in the same period of 2023.
• The company's nine-month revenue decreased by 34% to $181.830 million, compared to $276.241 million in the prior year period.
• Adjusted EBITDA for the third quarter was a loss of $973,000, compared to a profit of $9.659 million in the same quarter of 2023.
• Adjusted EBITDA for the nine months ended September 30, 2024, was $13.042 million, down from $18.230 million in the same period of 2023.
• The biofuel segment experienced a significant decrease in revenue due to production issues and lower prices, while the chemical segment saw a slight increase in revenue but a decrease in gross profit.
• The company held 5.0 million RINs with a fair market value of $2.556 million as of September 30, 2024, compared to 4.2 million RINs with a fair market value of $6.971 million at the same time last year.

Sentiment

Score: 3

Explanation: The document presents a negative outlook due to significant decreases in revenue, net income, and adjusted EBITDA, along with production challenges and market volatility. While there are some positives, the overall tone is concerning from an investment perspective.

Positives

• The chemical segment experienced a slight revenue increase of 0.5% in Q3 2024 compared to Q3 2023.
• The company received a legal settlement of $2.750 million, contributing to other income for the nine months ended September 30, 2024.
• Operating expenses decreased by $302,000 in Q3 2024 and $650,000 for the nine months ended September 30, 2024, due to lower administrative and research and development expenses.

Negatives

• The company reported a net loss of $1.195 million in Q3 2024, a significant decrease from the net income of $2.776 million in Q3 2023.
• Consolidated revenue decreased by 56% in Q3 2024 and 34% for the nine months ended September 30, 2024.
• The biofuel segment experienced a 66.4% revenue decrease in Q3 2024 due to lower sales volumes and prices.
• Gross profit decreased by $3.487 million in Q3 2024 and $2.854 million for the nine months ended September 30, 2024.
• The chemical segment's gross profit decreased by 50.5% in Q3 2024.
• Adjusted EBITDA decreased significantly in both Q3 and the nine-month period of 2024 compared to 2023.
• Production issues in the biofuel segment, stemming from equipment supplier delays, negatively impacted sales volumes.
• Lower renewable fuel and RIN prices contributed to reduced revenue in the biofuel segment.
• The company experienced a LIFO liquidation of $935 in the nine months ended September 30, 2024.

Risks

• The company faces commodity price risk in both its chemical and biofuel segments, with fluctuations in raw material costs impacting profitability.
• The biofuel segment is subject to market volatility, with prices influenced by renewable fuel and RIN prices.
• Production issues, such as equipment supplier delays, can disrupt operations and negatively impact sales volumes.
• The company's reliance on a few major refiners/blenders for biofuel sales poses a risk if these customers reduce or cease purchases.
• The company's derivative instruments do not qualify for hedge accounting, leading to potential volatility in net income due to mark-to-market adjustments.
• The company's financial performance is sensitive to changes in the prices of key raw materials and conversion costs.
• The company's future performance is subject to various risks and uncertainties, including those related to market conditions, production, and regulatory changes.

Future Outlook

The company believes that existing cash balances, cash flow from operations, and borrowing capacity will be sufficient to fund operations, product development, cash dividends, and capital requirements for the foreseeable future. The company intends to fund future capital requirements from cash flow, existing cash, and borrowings under its credit facility, and does not believe there will be a need to issue any securities.

Management Comments

• Management believes that the diversity of each segment strengthens the company in the ability to utilize resources and is committed to growing each segment.
• Management believes that adjusted EBITDA permits a comparative assessment of our operating performance and liquidity, relative to performance and liquidity based on GAAP results.
• Management has determined that none of the net deferred tax assets are more likely than not to be realized.

Industry Context

The report highlights the impact of market volatility and regulatory factors on the biofuel industry, particularly the fluctuations in renewable fuel and RIN prices. The company's performance is also affected by production challenges, which are common in the manufacturing sector. The company's reliance on a few major customers is a risk factor that is not uncommon in the industry.

Comparison to Industry Standards

• FutureFuel's biofuel segment is facing challenges similar to other biodiesel producers, with fluctuating RIN prices and production issues impacting profitability. Comparatively, companies like Renewable Energy Group (REGI) and Darling Ingredients (DAR) also experience volatility in their biofuel segments due to similar market factors.
• The chemical segment's performance is mixed, with some growth in specific markets but overall decline in gross profit. This is similar to other specialty chemical companies that face varying demand and pricing pressures in different end markets. Companies like Eastman Chemical (EMN) and Celanese (CE) also experience fluctuations in their chemical segments due to market conditions.
• FutureFuel's reliance on derivative instruments to manage commodity price risk is a common practice in the industry, but the lack of hedge accounting can lead to volatility in reported earnings. Other companies in the energy and chemical sectors also use derivatives, but the accounting treatment and impact on earnings can vary.
• The company's LIFO inventory accounting method can lead to fluctuations in gross profit, which is a common issue for companies using this method. Other companies using LIFO, such as some in the oil and gas industry, also experience similar impacts on their financial results.

Related Party Transactions

• FutureFuel enters into transactions with companies affiliated with or controlled by a director and significant shareholder.
• Revenues, expenses, prepaid amounts, and unpaid amounts related to these transactions are captured in the accompanying consolidated financial statements as related party line items.
• Related party revenues are the result of sales of biodiesel, petrodiesel, blends, other petroleum products, and other similar or related products to these related parties.
• Related party cost of goods sold and distribution are the result of sales and purchases of biodiesel, petrodiesel, blends, and other petroleum products with these related parties along with the associated expense from storage and terminalling services provided by these related parties.

Stakeholder Impact

• Shareholders will be negatively impacted by the decrease in net income and adjusted EBITDA, as well as the reduced dividend payout.
• Employees may be affected by potential cost-cutting measures due to the company's financial challenges.
• Customers may experience supply disruptions due to production issues in the biofuel segment.
• Suppliers may face reduced demand due to lower production volumes.
• Creditors may be concerned about the company's ability to meet its financial obligations.

Key Dates

Keywords

biofuel, chemicals, RINs, revenue, EBITDA, net income, production, commodity prices, derivative instruments, LIFO, blenders tax credit